Playback speed
10 seconds
SGO 2024 Insights: "RUBY Part 1 & Part 2 Trial - Dostarlimab + Chemo for Primary Advanced/Recurrent Endometrial Cancer & PARPi Maintenance in Patients Receiving Dostarlimab + Chemo"
By
Insights from 2024 SGO Annual Meeting
FEATURING
Mansoor Raza Mirza
By
Insights from 2024 SGO Annual Meeting
FEATURING
Mansoor Raza Mirza
0 views
April 9, 2024
Comments 0
Login to view comments.
Click here to Login